Evaxion A EVAX
NASDAQ EVAX
$2.75 -0.25 (-8.33%)
At close: Nov 9, 2026 · 4:00 PM EST

Evaxion A (EVAX) Long-Term Debt Repayments (2022)

Updated

Evaxion A's Long-Term Debt Repayments was -$399,000 in FY2025, compared with -$805,000 in FY2024.

Analysis

Evaxion A (EVAX) Long-Term Debt Repayments (2022) Analysis & Trends

From FY2021 onward, Evaxion A has reported Long-Term Debt Repayments for 5 years.

  • Annual Long-Term Debt Repayments has moved between -$805,000 (FY2024) and -$63,000 (FY2021) over five years.
  • Per Business Quant data, Long-Term Debt Repayments in earlier years was -$805,000 in FY2024, -$371,000 in FY2023, -$119,000 in FY2022 and -$63,000 in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Repayment (Qtr)
1 Eli Lilly 1,261.99 Bn 1,235.61 Bn 20.46 Bn -
2 Johnson & Johnson 678.93 Bn 598.79 Bn 17.30 Bn 1.00 Mn
3 AbbVie 518.29 Bn 486.30 Bn 13.12 Bn -
4 Merck 365.98 Bn 328.92 Bn 13.19 Bn -
5 Novartis Ag 316.85 Bn 290.09 Bn - -
6 Astrazeneca 293.40 Bn 267.29 Bn 13.26 Bn -4.91 Bn
7 Amgen 251.78 Bn 203.43 Bn 7.58 Bn 3.05 Bn
8 Gilead Sciences 210.61 Bn 185.71 Bn 6.73 Bn 19.00 Mn
9 Pfizer 166.87 Bn 114.23 Bn 12.56 Bn -
10 Evaxion A 17.56 Mn -48.69 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2022 30,000.00
Mar 31, 2022 30,000.00
API Access

Evaxion A Long-Term Debt Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=EVAX&period=max&api_key=YOUR_API_KEY